The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Open accessAbstract
Background Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades. To assess whether this pathway is causally relevant to coronary heart disease, we studied a functional genetic variant known to affect IL6R signalling.Methods In a collaborative meta-analysis, we studied Asp358Ala (rs2228145) in IL6R in relation to a panel of conventional risk factors and inflammation biomarkers in 125,222 participants. We also compared the frequency of Asp358Ala in 51,441 patients with coronary heart disease and in 136,226 controls. To gain insight into possible mechanisms, we assessed Asp358Ala in relation to localised gene expression and to postlipopolysaccharide stimulation of interleukin 6.Findings The minor allele frequency of Asp358Ala was 39%. Asp358Ala was not associated with lipid concentrations, blood pressure, adiposity, dysglycaemia, or smoking (p value for association per minor allele ≥0·04 for each). By contrast, for every copy of 358Ala inherited, mean concentration of IL6R increased by 34·3% (95% CI 30·4-38·2) and of interleukin 6 by 14·6% (10·7-18·4), and mean concentration of C-reactive protein was reduced by 7·5% (5·9-9·1) and of fibrinogen by 1·0% (0·7-1·3). For every copy of 358Ala inherited, risk of coronary heart disease was reduced by 3·4% (1·8-5·0). Asp358Ala was not related to IL6R mRNA levels or interleukin-6 production in monocytes.Interpretation Large-scale human genetic and biomarker data are consistent with a causal association between IL6R-related pathways and coronary heart disease.Funding British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research, Cambridge Biomedical Research Centre; BUPA Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genetic evidence suggests that IL-6 may be causal for atherosclerotic cardiovascular disease, 24,25”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Population genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,153
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Research works printed but not linked: 2
- Lamas, 2011, Mechanisms underlying the generation of soluble IL-6 soluble receptor (sIL-6R) in rheumatoid arthritis: mRNA alternative splicing and proteolytic cleavage as independent contributors, Arthritis Rheum, 63, 383
- Genovese, 2009, Analysis of low-density lipoprotein and adverse events in rheumatoid arthritis patients treated with tocilizumab plus statins: data from five phase III clinical trials, Rheumatology (Oxford), 48, I81
Cited by
Sorted by citations
Items 301–400 of 823
Blocking only the bad side of IL-6 in inflammation and cancer
Rose‐John, S. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155690 · Cited by 44
Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion
Hartman, M. H. T., Vreeswijk‐Baudoin, I., Groot, H. E., van de Kolk, K. W. A., de Boer, R. A., Leach, I. M., Vliegenthart, R., Silljé, H. H. W., & van der Harst, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167195 · Cited by 43
The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities
Hartiala, J., Schwartzman, W. S., Gabbay, J., Ghazalpour, A., Bennett, B. J., & Allayee, H. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0641-6 · Cited by 44
Proteolytic control of Interleukin-11 and Interleukin-6 biology
Lokau, J., Agthe, M., Flynn, C. M., & Garbers, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.008 · Cited by 43
de Jager, S. C. A., Meeuwsen, J. A. L., van Pijpen, F. M., Zoet, G. A., Barendrecht, A. D., Franx, A., Pasterkamp, G., van Rijn, B. B., Goumans, M., & den Ruijter, H. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.012 · Cited by 44
Ridker, P. M. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12862 · Cited by 43
The cardiometabolic conditions of psoriatic disease
Toussirot, É., Gallais-Sérézal, I., & Aubin, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970371 · Cited by 42
Tøllefsen, I. M., Shetelig, C., Seljeflot, I., Eritsland, J., Hoffmann, P., & Andersen, G. Ø. (2021) · Open Heart · doi:10.1136/openhrt-2021-001869 · Cited by 41
Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
Rodríguez‐Rodríguez, L., López‐Mejías, R., García-Bermúdez, M., González‐Juanatey, C., González-Gay, M. Á., & Martin, J. J. (2012) · Mediators of Inflammation · doi:10.1155/2012/574817 · Cited by 42
Circulating “LncPPARδ” From Monocytes as a Novel Biomarker for Coronary Artery Diseases
Cai, Y., Yang, Y., Chen, X., He, D., Zhang, X., Wen, X., Hu, J., Fu, C., Qiu, D., José, P. A., et al. (2016) · Medicine · doi:10.1097/md.0000000000002360 · Cited by 42
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth
Ho, H. C. H., Maddaloni, E., & Buzzetti, R. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3134 · Cited by 41
Inferring Causal Relationships between Risk Factors and Outcomes Using Genetic Variation
Burgess, S., Foley, C. N., & Zuber, V. (2019) · Wiley eBooks · doi:10.1002/9781119487845.ch23 · Cited by 40
Human Genomics and Drug DevelopmentPreprint
Schmidt, A. F., Hingorani, A. D., & Finan, C. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039230 · Cited by 40
Ferreira, J. P., Vasques‐Nóvoa, F., Neves, J. S., Zannad, F. M., & Leite-Moreira, A. F. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117461 · Cited by 41
Huang, Y., Park, E., Edirisinghe, I., & Burton‐Freeman, B. M. (2016) · Food & Function · doi:10.1039/c6fo00995f · Cited by 40
RVX 208: A novel BET protein inhibitor, role as an inducer of apo A‐I/ HDL and beyond
Ghosh, G. C., Bhadra, R., Ghosh, R. K., Banerjee, K., & Gupta, A. (2017) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12265 · Cited by 42
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Storey, B. C., Staplin, N., Haynes, R., Reith, C. A., Emberson, J., Herrington, W. G., Wheeler, D. C., Walker, R. J., Fellström, B., Wanner, C., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.09.011 · Cited by 43
Activating mutations of the gp130/JAK/STAT pathway in human diseases
Lokau, J., & Garbers, C. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.007 · Cited by 41
Giollabhui, N. M., Slaney, C., Hemani, G., Foley, É. M., van der Most, P. J., Nolte, I. M., Snieder, H., Smith, G. D., Khandaker, G. M., & Hartman, C. A. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03372-w · Cited by 51
Robert, J., Lehner, M., Frank, S., Perisa, D., von Eckardstein, A., & Rohrer, L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301363 · Cited by 39
McGowan, L. M., Smith, G. D., Gaunt, T. R., & Richardson, T. G. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz155 · Cited by 40
“For our two-sample MR analysis, we harnessed genetic instrument data for 10 circulating inflammatory cytokines or soluble cytokine receptors (Supplementary Material, Table S1) from summary statistics of previously published GWAS (18,19,23,48).”
Slaney, C., Sallis, H., Jones, H. J., Dardani, C., CHARGE Inflammation Working Group, Tilling, K. M., Munafo, M. R., Smith, G. D., Mahedy, L., & Khandaker, G. M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.010 · Cited by 39
IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention
Schumertl, T., Lokau, J., & Garbers, C. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s485684 · Cited by 45
Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
Morieri, M. L., Passaro, A., & Zuliani, G. (2017) · Mediators of Inflammation · doi:10.1155/2017/1396398 · Cited by 40
Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review
Rahvar, A., Haas, C. S., Danneberg, S., & Harbeck, B. (2017) · BioMed Research International · doi:10.1155/2017/3691913 · Cited by 40
Ritchie, S. C., Kettunen, J., Brożyńska, M., Nath, A. P., Havulinna, A. S., Männistö, S., Perola, M., Salomaa, V. V., Ala‐Korpela, M., Abraham, G., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223692 · Cited by 37
Bargieł, W., Cierpiszewska, K., Maruszczak, K., Pakuła, A., Szwankowska, D., Wrzesińska, A., Gutowski, Ł., & Formanowicz, D. (2021) · Medicina · doi:10.3390/medicina57070701 · Cited by 41
Consumption of ultra-processed foods and IL-6 in two cohorts from high- and middle-income countries
dos Santos, F. S., Mintem, G. C., de Oliveira, I. O., Horta, B. L., Ramos, E., Lopes, C., & Gigante, D. P. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522000551 · Cited by 41
Interleukin-6 Receptor and Inflammatory Bowel Disease: A Mendelian Randomization Study
Liu, G., Jin, S., & Jiang, Q. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.059 · Cited by 38
Miwa, K., Tanaka, M. R., Okazaki, S., Furukado, S., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300350 · Cited by 35
Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions
Hong, J., Maron, D. J., Shirai, T., & Weyand, C. M. (2015) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.15.33 · Cited by 37
Atherothrombosis and the NLRP3 inflammasome – endogenous mechanisms of inhibition
Satish, M., & Agrawal, D. K. (2019) · Translational research · doi:10.1016/j.trsl.2019.08.003 · Cited by 39
Sánchez-Macarro, M., Rodríguez, J. P. M., Bernal, E., Pérez-Piñero, S., Victoria‐Montesinos, D., García‐Muñoz, A. M., Cánovas, F., Sánchez, J. C., & López-Román, F. J. (2020) · Nutrients · doi:10.3390/nu12051475 · Cited by 39
Carotid intimal medial thickness in rotating night shift is related to IL1β/IL6 axis
Rizza, S., Longo, S., Piciucchi, G., Romanello, D., Mavilio, M., Montagna, M., Coppeta, L., Martelli, E., Magrini, A., & Federici, M. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.028 · Cited by 37
Assessment of Atherosclerosis in Chronic Granulomatous Disease
Sibley, C. T., Estwick, T., Zavodni, A. E. H., Huang, C., Kwan, A. C., Soule, B. P., Priel, D. A. L., Remaley, A. T., Spergel, A. K. R., Turkbey, E. B., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006824 · Cited by 37
Linden, F., Domschke, G., Erbel, C., Akhavanpoor, M., Katus, H. A., & Gleissner, C. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00455 · Cited by 35
Skeoch, S., Cristinacce, P. L. H., Williams, H. A., Pemberton, P. W., Xu, D., Sun, J., James, J. M., Yuan, C., Hatsukami, T. S., Hockings, P. D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00989-w · Cited by 38
Georgakis, M. K., Malik, R., Gill, D., Franceschini, N., Sudlow, C. L. M., & Dichgans, M. (2019) · medRxiv · doi:10.1101/19007682 · Cited by 36
Soluble Interleukin-6 Receptor-Mediated Innate Immune Response to DNA and RNA Viruses
Wang, Q., Chen, X., Feng, J. J., Cao, Y., Song, Y., Wang, H., Zhu, C., Liu, S., & Zhu, Y. (2013) · Journal of Virology · doi:10.1128/jvi.01248-13 · Cited by 35
Arnold, N., & Köenig, W. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07105-7 · Cited by 34
Interleukin-1 in Coronary Artery Disease
Oikonomou, E. K., Tsaplaris, P., Anastasiou, A., Xenou, M., Lampsas, S., Siasos, G., Pantelidis, P., Theofilis, P., Tsatsaragkou, A., Κατσαρού, Ο., et al. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221017144734 · Cited by 35
Making sense of IL‐6 signalling cues in pathophysiology
Millrine, D., Jenkins, R. L., Hughes, S. T. O., & Jones, S. A. (2021) · FEBS Letters · doi:10.1002/1873-3468.14201 · Cited by 39
Qin, T., Ma, T., Huang, K., Lu, S., Zhong, J., & Li, J. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01215-5 · Cited by 36
Atherosclerosis: Recent trials, new targets and future directions
Ladeiras‐Lopes, R., Agewall, S., Tawakol, A. A., Staels, B., Stein, E. A., Mentz, R. J., Leite-Moreira, A. F., Zannad, F. M., & Köenig, W. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.013 · Cited by 34
Dalbeni, A., Giollo, A., Tagetti, A., Atanasio, S., Orsolini, G., Cioffi, G., Ognibeni, F., Rossini, M., Minuz, P., Fava, C., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.072 · Cited by 33
The Utility of Anti-Inflammatory Agents in Cardiovascular Disease
Kottoor, S. J., & Arora, R. R. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418778548 · Cited by 34
O’Donoghue, M. L., Glaser, R., Aylward, P. E., Cavender, M. A., Crisp, A., Fox, K. A. A., Laws, I., López-Sendón, J. L., Steg, P. G., Théroux, P., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.02.012 · Cited by 33
Blumenthal, J. A., Feger, B. J., Smith, P. J., Watkins, L. L., Jiang, W., Davidson, J. R. T., Hoffman, B. M., Ashworth, M., Mabe, S., Babyak, M. A., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.003 · Cited by 33
Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism
Ellis, K. L., Hooper, A. J., Burnett, J. R., & Watts, G. F. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.69 · Cited by 33
van Wijk, D. F., Boekholdt, S. M., Arsenault, B. J., Ahmadi‐Abhari, S., Wareham, N. J., Stroes, E. S. G., & Khaw, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002823 · Cited by 33
Kappelmann, N., Khandaker, G. M., Dal, H., Štochl, J., Kosidou, K., Jones, P. B., Dalman, C., & Karlsson, H. (2018) · Psychological Medicine · doi:10.1017/s0033291718000831 · Cited by 33
Metabolic Profiling of Adiponectin Levels in Adults
Borges, M. C., Barros, A. J. D., Ferreira, D. L. S., Casas, J. P., Horta, B. L., Mika Kivimaki, B., Meena Kumari, B., Menon, U., Gaunt, T. R., Ben‐Shlomo, Y., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001837 · Cited by 32
Zimmerman, A., & Kalra, D. K. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.03.120 · Cited by 33
The Effects of FABP4 on Cardiovascular Disease in the Aging Population
van der Ark-Vonk, E. M., Puijk, M. V., Pasterkamp, G., & van der Laan, S. W. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01196-5 · Cited by 35
Assessment of Inflammatory Biomarkers and Incident Atrial Fibrillation in Older Adults
Shitole, S. G., Heckbert, S. R., Marcus, G. M., Shah, S. J., Sotoodehnia, N., Walston, J. D., Reiner, A. P., Tracy, R. P., Psaty, B. M., & Kizer, J. R. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035710 · Cited by 32
Multilocus approaches for the measurement of selection on correlated genetic loci
Gompert, Z., Egan, S. P., Barrett, R. D. H., Feder, J. L., & Nosil, P. (2016) · Molecular Ecology · doi:10.1111/mec.13867 · Cited by 31
Human immunodeficiency virus and menopause
Kanapathipillai, R., Hickey, M., & Giles, M. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318282aa57 · Cited by 32
Blood HER2 and Uromodulin as Causal Mediators of CKD
Sjaarda, J., Gerstein, H. C., Yusuf, S., Treleaven, D. J., Walsh, M. W., Mann, J. F. E., Hess, S., & Paré, G. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070812 · Cited by 32
Happiness and Inflammatory Responses to Acute Stress in People With Type 2 Diabetes
Panagi, L., Poole, L., Hackett, R. A., & Steptoe, A. (2019) · Annals of Behavioral Medicine · doi:10.1093/abm/kay039 · Cited by 35
Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment
Arnold, N., & Köenig, W. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70020 · Cited by 33
Zhao, T. X., Newland, S. A., & Mallat, Z. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312287 · Cited by 32
Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system
Zhao, K., Yang, C., Li, P., Sun, W. Y., & Kong, X. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900680 · Cited by 30
“This may also explain certain unclear mechanisms in the link between inflammation and the progression of CVDs (Smith and Humphries, 2009; IL6R Genetics Consortium Emerging Risk Factors Collaboration, 2012; Xuan et al., 2016; Mitrokhin et al., 2017; Cheng et al., 2018).”
Valdés‐Márquez, E., Clarke, R., Hill, M., Watkins, H. C., & Hopewell, J. C. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad020 · Cited by 32
IL6 genetic perturbation mimicking IL-6 inhibition is associated with lower cardiometabolic risk
Zhang, L., Omarov, M., Xu, L., deGoma, E. M., Natarajan, P., & Georgakis, M. K. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00700-7 · Cited by 32
Yang, Y., Lian, Y.-T., Huang, S., Yang, Y., Cheng, L., & Liu, K. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358681 · Cited by 30
Hof, F. N. G. V. ’., Ruigrok, Y. M., Baas, A. F., Kiemeney, L. A. L. M., Vermeulen, S. H. H. M., Uitterlinden, A. G., Albert Hofman, D., Rivadeneira, F., Rinkel, G. J. E., & de Bakker, P. I. W. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000022 · Cited by 30
Orrem, H. L., Nilsson, P. H., Pischke, S. E., Kleveland, O., Yndestad, A., Ekholt, K., Damås, J. K., Espevik, T., Bendz, B., Halvorsen, B. L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02035 · Cited by 30
Dalbeni, A., Giollo, A., Bevilacqua, M., Cioffi, G., Tagetti, A., Cattazzo, F., Orsolini, G., Ognibeni, F., Minuz, P., Rossini, M., et al. (2020) · Hypertension Research · doi:10.1038/s41440-020-0441-1 · Cited by 30
COVID-19 and the Heart and Vasculature
KADOSH, B. S., Garshick, M. S., Gaztañaga, J., Moore, K. J., Newman, J. D., Pillinger, M. H., Ramasamy, R., Reynolds, H. R., Shah, B., Hochman, J. S., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314513 · Cited by 30
Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 Inhibition
Musunuru, K. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-080819-044918 · Cited by 32
Maierean, S. M., Webb, R. J., Banach, M., & Mazidi, M. (2022) · European Heart Journal Open · doi:10.1093/ehjopen/oeac039 · Cited by 32
Cederström, S., Lundman, P., Alfredsson, J., Hagström, E., Ravn‐Fischer, A., Söderberg, S., Yndigegn, T., Tornvall, P., & Jernberg, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-39051-3 · Cited by 30
Gigante, B., Strawbridge, R. J., Velásquez, I. M., Golabkesh, Z., Silveira, A. M. V., Goel, A., Baldassarre, D., Veglia, F., Tremoli, E., Clarke, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119980 · Cited by 30
Wang, Y., Hu, Y., Sha, Y.-H., Gao, J.-J., Ma, X., Li, S., Zhao, J., Qiu, Y., Lu, J., Huang, C., et al. (2015) · Inflammation · doi:10.1007/s10753-015-0194-1 · Cited by 30
Kelly, D., Kelleher, E. M., & Rothwell, P. M. (2025) · Stroke · doi:10.1161/strokeaha.124.047070 · Cited by 29
Coveney, S. A., McCabe, J. J., Murphy, S., O'Donnell, M. J., & Kelly, P. J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012825.pub2 · Cited by 30
Mendelian randomization studies on atherosclerotic cardiovascular disease: evidence and limitations
Hu, Q., Hao, P., Liu, Q., Dong, M., Gong, Y., Zhang, C., & Zhang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-9537-4 · Cited by 30
Characteristics of Interleukin-6 Signaling in Elective Cardiac Surgery—A Prospective Cohort Study
Puchinger, J., Ryz, S., Nixdorf, L., Edlinger-Stanger, M., Lassnigg, A. M., Wiedemann, D., Hiesmayr, M., Spittler, A., & Bernardi, M. H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030590 · Cited by 29
Flaim, J., Grundy, J. S., Baker, B. F., McGowan, M. P., & Kastelein, J. J. P. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000560 · Cited by 29
Estimating inflammatory risk in atherosclerotic cardiovascular disease: plaque over plasma?
Annink, M. E., Kraaijenhof, J. M., Beverloo, C. Y. Y., Oostveen, R. F., Verberne, H. J., Stroes, E. S. G., & Nurmohamed, N. S. (2024) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeae314 · Cited by 29
Mendelian randomization: Its impact on cardiovascular disease
Kawashiri, M., Tada, H., Nomura, A., & Yamagishi, M. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.04.007 · Cited by 28
Quagliariello, V., Bonelli, A., Caronna, A., Conforti, G., Iovine, M., Carbone, A., Berretta, M., Botti, G., & Maurea, N. (2020) · Cancers · doi:10.3390/cancers12113316 · Cited by 29
Grief Symptoms Promote Inflammation During Acute Stress Among Bereaved Spouses
Brown, R. L., LeRoy, A. S., Chen, M. A., Suchting, R., Jaremka, L. M., Liu, J., Heijnen, C. J., & Fagundes, C. P. (2022) · Psychological Science · doi:10.1177/09567976211059502 · Cited by 30
Luo, P., Shi, W., Wang, Y., Ma, H., Liu, T., Yan, D., Huo, S., Guo, J., Wang, M., Li, C., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118304 · Cited by 28
Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates
Ridker, P. M. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.060 · Cited by 28
Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease
Xu, C., Tsihlis, G., Chau, K., Trinh, K., Rogers, N. M., & Julovi, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052658 · Cited by 30
Self-Reported Cardiovascular Disease and the Risk of Lung Cancer, the HUNT Study
Hatlen, P., Langhammer, A., Carlsen, S. M., Salvesen, Ø. O., & Amundsen, T. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000180 · Cited by 27
Close, H. J., Mason, J. M., Wilson, D. W., Hungin, A. P. S., Jones, R. H., & Rubin, G. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139745 · Cited by 27
Welsh, P. I., Tuckwell, K., McInnes, I. B., & Sattar, N. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.016 · Cited by 28
Pedersen, K. M., Çolak, Y., Ellervik, C., Hasselbalch, H. C., Bojesen, S. E., & Nordestgaard, B. G. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100280 · Cited by 28
Roumeliotis, S. K., Veljkovic, A., Georgianos, P. I., Lazarević, G., Perišić, Z., Hadži-Djokić, J., Liakopoulos, V., & Kocic, G. M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3090120 · Cited by 34
The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer
Martínez-Pérez, C., Kay, C., Meehan, J., Gray, M., Dixon, J. M., & Turnbull, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111073 · Cited by 28
Nowakowska, M. K., Kim, T., Thompson, M. T., Bolton, K. L., Deswal, A., Lin, S. H., Scheet, P. A., Wehner, M. R., & Nead, K. T. (2022) · American Journal of Hematology · doi:10.1002/ajh.26465 · Cited by 28
Vos, A. G., Hulzebosch, A., Grobbee, D. E., Barth, R. E., & Klipstein‐Grobusch, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169986 · Cited by 27
Kurt, B., Rex, K., Reugels, M., Fordyce, C. B., Fudim, M., Sharma, A., Berger, M., Marx, N., Marx-Schütt, K., & Kahles, F. (2025) · Current Heart Failure Reports · doi:10.1007/s11897-025-00710-3 · Cited by 30
Interleukin and growth factor gene variants and risk of carpal tunnel syndrome
Burger, M. C., de Wet, H., & Collins, M. (2015) · Gene · doi:10.1016/j.gene.2015.03.047 · Cited by 26
Genetic variation associated with cardiovascular risk in autoimmune diseases
Perrotti, P. P., Aterido, A., Fernández‐Nebro, A., Cañete, J. D. D., Ferrándiz, C., Tornero, J., Gisbert, J. P., Domènech, E., Fernández‐Gutiérrez, B., Gomollón, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185889 · Cited by 27
Inflammation Revisited: Atherosclerosis in The Post-CANTOS Era
Köenig, W., & Deutsches Herzzentrum München, T. U. M. (2017) · European Cardiology Review · doi:10.15420/ecr.2017:18:1 · Cited by 26
Jones, R., Hardy, R., Sattar, N. A., Deanfield, J. E., Hughes, A. D., Kuh, D. J., Murray, E. T., Whincup, P. H., & Thomas, C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.11.011 · Cited by 28
Associations of Personality Traits With Chronic Low-Grade Inflammation in a Swiss Community Sample
Wagner, E.-Y. N., Ajdacic‐Gross, V., Strippoli, M. F., Gholam‐Rezaee, M., Glaus, J., Vandeleur, C. L., Castelao, E., Vollenweider, P., Preisig, M., & von Känel, R. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00819 · Cited by 30
Metadata
- Authors
- ‡
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- ‡
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 379
- Issue
- 9822
- Pages
- 1205-1213
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3316940
- OpenAlex
- W2139957955
- Cited by
- 823
- References
- 47
- Citations by year
- 2026: 48 · 2025: 46 · 2024: 63 · 2023: 46 · 2022: 50 · 2021: 69 · 2020: 73 · 2019: 57 · 2018: 61 · 2017: 60 · 2016: 58 · 2015: 48 · 2014: 72 · 2013: 48 · 2012: 23
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/014)
- Bupa Foundation
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- IL-6 receptor, coronary artery disease, rs2228145, genetic association, inflammation, C-reactive protein, fibrinogen, interleukin-6, chronic inflammation, cardiovascular risk factors, monocytes, gene expression
- MeSH terms
- Coronary Disease, Gene Frequency, Humans, Risk Factors, Genetic Variation, Signal Transduction, Causality, Inflammation Mediators, Receptors, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
